BJU International

Cover image for Vol. 113 Issue 5

Early View (Online Version of Record published before inclusion in an issue)

Edited By: Prokar Dasgupta

Impact Factor: 3.046

ISI Journal Citation Reports © Ranking: 2012: 15/73 (Urology & Nephrology)

Online ISSN: 1464-410X

VIEW

  1. 1 - 90
  1. Urological Oncology

    1. Role of fluorodeoxyglucose positron emission tomography (FDG PET)-computed tomography (CT) in the staging of bladder cancer

      Henry Goodfellow, Zaid Viney, Paul Hughes, Sheila Rankin, Giles Rottenberg, Simon Hughes, Felicity Evison, Prokar Dasgupta, Timothy O'Brien and Muhammad Shamim Khan

      Article first published online: 16 APR 2014 | DOI: 10.1111/bju.12608

  2. Upper Urinary Tract

    1. Active surveillance for renal angiomyolipoma: outcomes and factors predictive of delayed intervention

      Idir Ouzaid, Riccardo Autorino, Richard Fatica, Brian R. Herts, Gordon McLennan, Erick M. Remer and Georges-Pascal Haber

      Article first published online: 16 APR 2014 | DOI: 10.1111/bju.12604

  3. Functional Urology

    1. Role of urinary cations in the aetiology of bladder symptoms and interstitial cystitis

      C. Lowell Parsons, Timothy Shaw, Zoltan Berecz, Yongxuan Su, Paul Zupkas and Sulabha Argade

      Article first published online: 16 APR 2014 | DOI: 10.1111/bju.12603

  4. Urological Oncology

    1. Muscle-invasive bladder cancer: evaluating treatment and survival in the National Cancer Data Base

      Angela B. Smith, Allison M. Deal, Michael E. Woods, Eric M. Wallen, Raj S. Pruthi, Ronald C. Chen, Matthew I. Milowsky and Matthew E. Nielsen

      Article first published online: 16 APR 2014 | DOI: 10.1111/bju.12601

  5. Reviews

    1. Is intermittent androgen-deprivation therapy beneficial for patients with advanced prostate cancer?

      Johannes M. Wolff, Per-Anders Abrahamsson, Jacques Irani and Fernando Calais da Silva

      Article first published online: 16 APR 2014 | DOI: 10.1111/bju.12626

  6. Comments

    1. The forgotten ureteric stent: what next?

      John Withington, Kathie Wong, Matthew Bultitude and Tim O'Brien

      Article first published online: 16 APR 2014 | DOI: 10.1111/bju.12357

  7. Comment

    1. ‘Measurement for Improvement Not Judgement’ – the Case of Percutaneous Nephrolithotomy

      John Withington, James Armitage, William Finch, Ben Hughes, Jonathan M. Glass, Oliver J. Wiseman, Stuart O. Irving and Neill A. Burgess

      Article first published online: 16 APR 2014 | DOI: 10.1111/bju.12660

  8. Urological Oncology

    1. Hemi salvage high-intensity focused ultrasound (HIFU) in unilateral radiorecurrent prostate cancer: a prospective two-centre study

      Eduard Baco, Albert Gelet, Sébastien Crouzet, Erik Rud, Olivier Rouvière, Hélène Tonoli-Catez, Viktor Berge, Jean-Yves Chapelon and Heidi B. Eggesbø

      Article first published online: 16 APR 2014 | DOI: 10.1111/bju.12545

  9. Upper Urinary Tract

  10. Translational Science

  11. Urological Oncology

    1. Prognosis of patients with pelvic lymph node (LN) metastasis after radical prostatectomy: Value of extranodal extension and size of the largest LN metastasis

      Niccolo M. Passoni, Harun Fajkovic, Evanguelos Xylinas, Luis Kluth, Christian Seitz, Brian D. Robinson, Morgan Rouprêt, Felix K. Chun, Yair Lotan, Claus G. Roehrborn, Joseph J. Crivelli, Pierre I. Karakiewicz, Douglas S. Scherr, Michael Rink, Markus Graefen, Paul Schramek, Alberto Briganti, Francesco Montorsi, Ashutosh Tewari and Shahrokh F. Shariat

      Article first published online: 3 APR 2014 | DOI: 10.1111/bju.12342

    2. Nephron-sparing management vs radical nephroureterectomy for low- or moderate-grade, low-stage upper tract urothelial carcinoma

      Jay Simhan, Marc C. Smaldone, Brian L. Egleston, Daniel Canter, Steven N. Sterious, Anthony T. Corcoran, Serge Ginzburg, Robert G. Uzzo and Alexander Kutikov

      Article first published online: 3 APR 2014 | DOI: 10.1111/bju.12341

    3. Indications, results and safety profile of transperineal sector biopsies (TPSB) of the prostate: a single centre experience of 634 cases

      Lona Vyas, Peter Acher, Janette Kinsella, Ben Challacombe, Richard T.M. Chang, Paul Sturch, Declan Cahill, Ashish Chandra and Richard Popert

      Article first published online: 3 APR 2014 | DOI: 10.1111/bju.12282

    4. Incidence and predictors of understaging in patients with clinical T1 urothelial carcinoma undergoing radical cystectomy

      Jacob T. Ark, Kirk A. Keegan, Daniel A. Barocas, Todd M. Morgan, Matthew J. Resnick, Chaochen You, Michael S. Cookson, David F. Penson, Rodney Davis, Peter E. Clark, Joseph A. Smith Jr and Sam S. Chang

      Article first published online: 3 APR 2014 | DOI: 10.1111/bju.12245

    5. Genetic polymorphisms modify bladder cancer recurrence and survival in a USA population-based prognostic study

      Angeline S. Andrew, Jiang Gui, Ting Hu, Asaf Wyszynski, Carmen J. Marsit, Karl T. Kelsey, Alan R. Schned, Sam A. Tanyos, Eben M. Pendleton, Rebecca M. Ekstrom, Zhongze Li, Michael S. Zens, Mark Borsuk, Jason H. Moore and Margaret R. Karagas

      Article first published online: 26 MAR 2014 | DOI: 10.1111/bju.12641

    6. Does prostate HistoScanning™ play a role in detecting prostate cancer in routine clinical practice? Results from three independent studies

      Saqib Javed, Eliot Chadwick, Albert A. Edwards, Sabeena Beveridge, Robert Laing, Simon Bott, Christopher Eden and Stephen Langley

      Article first published online: 20 MAR 2014 | DOI: 10.1111/bju.12568

  12. Functional Urology

    1. Phase III, randomised, double-blind, placebo-controlled study of the β3-adrenoceptor agonist mirabegron, 50 mg once daily, in Japanese patients with overactive bladder

      Osamu Yamaguchi, Eiji Marui, Hidehiro Kakizaki, Yukio Homma, Yasuhiko Igawa, Masayuki Takeda, Osamu Nishizawa, Momokazu Gotoh, Masaki Yoshida, Osamu Yokoyama, Narihito Seki, Yasushi Ikeda and Sumito Ohkawa

      Article first published online: 17 MAR 2014 | DOI: 10.1111/bju.12649

  13. Urological Oncology

    1. Neoadjuvant chemotherapy for bladder cancer does not increase risk of perioperative morbidity

      David C. Johnson, Matthew E. Nielsen, Jonathan Matthews, Michael E. Woods, Eric M. Wallen, Raj S. Pruthi, Matthew I. Milowsky and Angela B. Smith

      Article first published online: 14 MAR 2014 | DOI: 10.1111/bju.12585

    2. Subclassification of upper urinary tract urothelial carcinoma by the neutrophil-to-lymphocyte ratio (NLR) improves prediction of oncological outcome

      Hao-Lun Luo, Yen-Ta Chen, Yao-Chi Chuang, Yuan-Tso Cheng, Wei-Ching Lee, Chih-Hsiung Kang and Po-Hui Chiang

      Article first published online: 14 MAR 2014 | DOI: 10.1111/bju.12582

    3. Prevalence of dyslipidaemia in patients with renal cell carcinoma: a case-control study in China

      Gui-Ming Zhang, Yao Zhu, Lei Luo, Hai-Liang Zhang, Cheng-Yuan Gu, Li-Jiang Sun and Ding-Wei Ye

      Article first published online: 14 MAR 2014 | DOI: 10.1111/bju.12581

  14. Functional Urology

    1. A clinical evaluation of a sensor to detect blockage due to crystalline biofilm formation on indwelling urinary catheters

      Adele Long, Julia Edwards, Richard Thompson, Debbie A. Lewis and Anthony G. Timoney

      Article first published online: 14 MAR 2014 | DOI: 10.1111/bju.12577

  15. Comments

  16. Functional Urology

  17. Reviews

  18. Functional Urology

    1. A case-control study: are urological procedures risk factors for the development of infective endocarditis?

      Amar R. Mohee, Robert West, Wazir Baig, Ian Eardley and Jonathan A.T. Sandoe

      Article first published online: 5 MAR 2014 | DOI: 10.1111/bju.12550

  19. Urological Oncology

    1. Impact of the type of ureteroileal anastomosis on renal function measured by diuretic scintigraphy: long-term results of a prospective randomized study

      Ahmed M. Harraz, Ahmed Mosbah, Mohamed Abdel-Latif, Ahmed El-Assmy, Hossam Gad and Atallah A. Shaaban

      Article first published online: 5 MAR 2014 | DOI: 10.1111/bju.12511

    2. Limited ability of existing nomograms to predict outcomes in men undergoing active surveillance for prostate cancer

      Siao-Yi Wang, Janet E. Cowan, K. Clint Cary, June M. Chan, Peter R. Carroll and Matthew R. Cooperberg

      Article first published online: 20 FEB 2014 | DOI: 10.1111/bju.12554

    3. Metabolic atrophy and 3-T 1H-magnetic resonance spectroscopy correlation after radiation therapy for prostate cancer

      Valeria Panebianco, Flavio Barchetti, Daniela Musio, Valerio Forte, Alberto Pace, Francesca De Felice, Giovanni Barchetti, Vincenzo Tombolini and Carlo Catalano

      Article first published online: 20 FEB 2014 | DOI: 10.1111/bju.12553

  20. Translational Science

    1. Intravesical administration of green tea extract attenuates the inflammatory response of bacterial cystitis – a rat model

      Shilo Rosenberg, Ray Horowitz, Shunit Coppenhagen-Glazer, Galina Pizov, Anna Elia, Ofer N. Gofrit, Isaac Ginsburg and Dov Pode

      Article first published online: 20 FEB 2014 | DOI: 10.1111/bju.12544

  21. Upper Urinary Tract

    1. Does body mass index impact the outcomes of tubeless percutaneous nephrolithotomy?

      Nicholas J. Kuntz, Andreas Neisius, Gastón M. Astroza, Matvey Tsivian, Muhammad W. Iqbal, Ramy Youssef, Michael N. Ferrandino, Glenn M. Preminger and Michael E. Lipkin

      Article first published online: 20 FEB 2014 | DOI: 10.1111/bju.12538

  22. Reviews

    1. Malnourishment in bladder cancer and the role of immunonutrition at the time of cystectomy: an overview for urologists

      Gavish Munbauhal, Sarah J. Drouin, Pierre Mozer, Pierre Colin, Véronique Phé, Olivier Cussenot and Morgan Rouprêt

      Article first published online: 20 FEB 2014 | DOI: 10.1111/bju.12529

  23. Urological Oncology

    1. Patients with prostate cancer continue to have excess mortality up to 15 years after diagnosis

      Olga Husson, Liza N. van Steenbergen, Evert L. Koldewijn, Philip M. Poortmans, Jan Willem W. Coebergh and Maryska L.G. Janssen-Heijnen

      Article first published online: 20 FEB 2014 | DOI: 10.1111/bju.12519

  24. Reviews

    1. Recent insights into NF-κB signalling pathways and the link between inflammation and prostate cancer

      Daniel P. Nguyen, Jinyi Li, Shalini S. Yadav and Ashutosh K. Tewari

      Article first published online: 20 FEB 2014 | DOI: 10.1111/bju.12488

  25. Urological Oncology

    1. Positive vascular wall margins have minimal impact on cancer outcomes in patients with non-metastatic renal cell carcinoma (RCC) with tumour thrombus

      E. Jason Abel, Alonso Carrasco, Jose Karam, Pheroze Tamboli, Scott Delacroix, Ara A. Vaporciyan and Christopher G. Wood

      Article first published online: 19 FEB 2014 | DOI: 10.1111/bju.12515

  26. Translational Science

    1. Astaxanthin modulates osteopontin and transforming growth factor β1 expression levels in a rat model of nephrolithiasis: a comparison with citrate administration

      Manju Alex, M.V. Sauganth Paul, M. Abhilash, Varghese V. Mathews, T.V. Anilkumar and R. Harikumaran Nair

      Article first published online: 19 FEB 2014 | DOI: 10.1111/bju.12537

  27. Urological Oncology

    1. Sepsis and ‘superbugs’: should we favour the transperineal over the transrectal approach for prostate biopsy?

      Jeremy P. Grummet, Mahesha Weerakoon, Sean Huang, Nathan Lawrentschuk, Mark Frydenberg, Daniel A. Moon, Mary O'Reilly and Declan Murphy

      Article first published online: 19 FEB 2014 | DOI: 10.1111/bju.12536

  28. Surgical Education

    1. Live surgical education: a perspective from the surgeons who perform it

      Shahid A.A. Khan, Richard T.M. Chang, Kamran Ahmed, Thomas Knoll, Roland van Velthoven, Ben Challacombe, Prokar Dasgupta and Abhay Rane

      Article first published online: 19 FEB 2014 | DOI: 10.1111/bju.12283

  29. Urological Oncology

    1. Implementing the use of nomograms by choosing threshold points in predictive models: 2012 updated Partin Tables vs a European predictive nomogram for organ-confined disease in prostate cancer

      Ángel Borque, Jose Rubio-Briones, Luis M. Esteban, Gerardo Sanz, Jose Domínguez-Escrig, Miguel Ramírez-Backhaus, Ana Calatrava and Eduardo Solsona

      Article first published online: 14 FEB 2014 | DOI: 10.1111/bju.12532

    2. Association of pretreatment neutrophil-to-lymphocyte ratio (NLR) and overall survival (OS) in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with first-line docetaxel

      Philipp Nuhn, Ajay M. Vaghasia, Jatinder Goyal, Xian C. Zhou, Michael A. Carducci, Mario A. Eisenberger and Emmanuel S. Antonarakis

      Article first published online: 14 FEB 2014 | DOI: 10.1111/bju.12531

    3. Reporting combined outcomes with Trifecta and survival, continence, and potency (SCP) classification in 337 patients with prostate cancer treated with image-guided hypofractionated radiotherapy

      Barbara A. Jereczek-Fossa, Dario Zerini, Cristiana Fodor, Luigi Santoro, Andrea Maucieri, Marianna A. Gerardi, Barbara Vischioni, Raffaella Cambria, Cristina Garibaldi, Federica Cattani, Andrea Vavassori, Deliu V. Matei, Gennaro Musi, Ottavio De Cobelli and Roberto Orecchia

      Article first published online: 14 FEB 2014 | DOI: 10.1111/bju.12530

    4. Reflex fluorescence in situ hybridization assay for suspicious urinary cytology in patients with bladder cancer with negative surveillance cystoscopy

      Philip H. Kim, Ranjit Sukhu, Billy H. Cordon, John P. Sfakianos, Daniel D. Sjoberg, A. Ari Hakimi, Guido Dalbagni, Oscar Lin and Harry W. Herr

      Article first published online: 14 FEB 2014 | DOI: 10.1111/bju.12516

    5. Positive surgical margins: rate, contributing factors and impact on further treatment: findings from the Prostate Cancer Registry

      Sue M. Evans, Jeremy L. Millar, Mark Frydenberg, Declan G. Murphy, Ian D. Davis, Tim Spelman, Damien M. Bolton, Graham G. Giles, Joanne Dean, Anthony J. Costello, Albert G. Frauman, Paul A. Kearns, Laura Day, Christopher Daniels and John J. McNeill

      Article first published online: 14 FEB 2014 | DOI: 10.1111/bju.12509

  30. Translational Science

    1. Cyclooxygenase-2 inhibitor suppresses tumour progression of prostate cancer bone metastases in nude mice

      Marta Garcia, Roberto Velez, Cleofé Romagosa, Blanca Majem, Núria Pedrola, Mireia Olivan, Marina Rigau, Marc Guiu, Roger R. Gomis, Juan Morote, Jaume Reventós and Andreas Doll

      Article first published online: 14 FEB 2014 | DOI: 10.1111/bju.12503

  31. Urological Oncology

    1. Cytoreductive nephrectomy in patients with metastatic non-clear-cell renal cell carcinoma (RCC)

      Ayal A. Aizer, Yuksel Urun, Rana R. McKay, Adam S. Kibel, Paul L. Nguyen and Toni K. Choueiri

      Article first published online: 14 FEB 2014 | DOI: 10.1111/bju.12442

    2. Impact of androgen suppression and zoledronic acid on bone mineral density and fractures in the Trans-Tasman Radiation Oncology Group (TROG) 03.04 Randomised Androgen Deprivation and Radiotherapy (RADAR) randomized controlled trial for locally advanced prostate cancer

      James W. Denham, Michael Nowitz, David Joseph, Gillian Duchesne, Nigel A. Spry, David S. Lamb, John Matthews, Sandra Turner, Chris Atkinson, Keen-Hun Tai, Nirdosh Kumar Gogna, Lizbeth Kenny, Terry Diamond, Richard Smart, David Rowan, Pablo Moscato, Renato Vimieiro, Richard Woodfield, Kevin Lynch, Brett Delahunt, Judy Murray, Cate D'Este, Patrick McElduff, Allison Steigler, Allison Kautto and Jean Ball

      Article first published online: 11 FEB 2014 | DOI: 10.1111/bju.12497

    3. The impact of perioperative blood transfusion on survival after nephrectomy for non-metastatic renal cell carcinoma (RCC)

      Brian J. Linder, R. Houston Thompson, Bradley C. Leibovich, John C. Cheville, Christine M. Lohse, Dennis A. Gastineau and Stephen A. Boorjian

      Article first published online: 29 JAN 2014 | DOI: 10.1111/bju.12535

  32. Upper Urinary Tract

    1. The protective role of coenzyme Q10 in renal injury associated with extracorporeal shockwave lithotripsy: a randomised, placebo-controlled clinical trial

      Julia Carrasco, Francisco J. Anglada, Juan P. Campos, Jordi Muntané, Maria J. Requena and Javier Padillo

      Article first published online: 29 JAN 2014 | DOI: 10.1111/bju.12485

  33. Urological Oncology

    1. Comparison of high-dose (86.4 Gy) IMRT vs combined brachytherapy plus IMRT for intermediate-risk prostate cancer

      Daniel E. Spratt, Zachary S. Zumsteg, Pirus Ghadjar, Marisa A. Kollmeier, Xin Pei, Gilad Cohen, William Polkinghorn, Yoshiya Yamada and Michael J. Zelefsky

      Article first published online: 22 JAN 2014 | DOI: 10.1111/bju.12514

  34. Functional Urology

    1. You have full text access to this OnlineOpen article
  35. Robotics and Laparoscopy

    1. Lateral temperature spread of monopolar, bipolar and ultrasonic instruments for robot-assisted laparoscopic surgery

      Lukas J. Hefermehl, Remo A. Largo, Thomas Hermanns, Cédric Poyet, Tullio Sulser and Daniel Eberli

      Article first published online: 22 JAN 2014 | DOI: 10.1111/bju.12498

    2. External validation of preoperative and postoperative nomograms for prediction of cancer-specific survival, overall survival and recurrence after robot-assisted radical cystectomy for urothelial carcinoma of the bladder

      Ali Al-Daghmin, Stephen English, Eric C. Kauffman, Rakeeba Din, Aabroo Khan, Johar R. Syed, Jenna Sztorc, Diana Mehedint, Mohammad Sharif, Yi Shi, Gregory Wilding and Khurshid A. Guru

      Article first published online: 22 JAN 2014 | DOI: 10.1111/bju.12484

  36. Upper Urinary Tract

  37. Urological Oncology

    1. Stage, grade and pathological characteristics of bladder cancer in the UK: British Association of Urological Surgeons (BAUS) Urological Tumour Registry

      Gregory B. Boustead, Sarah Fowler, Rajiv Swamy, Roger Kocklebergh, Luke Hounsome, on behalf of the Section of Oncology, and BAUS

      Article first published online: 22 JAN 2014 | DOI: 10.1111/bju.12468

    2. Higher rates of upgrading and upstaging in older patients undergoing radical prostatectomy and qualifying for active surveillance

      Jonas Busch, Ahmed Magheli, Natalia Leva, Michelle Ferrari, Juergen Kramer, Christian Klopf, Carsten Kempkensteffen, Kurt Miller, James D. Brooks and Mark L. Gonzalgo

      Article first published online: 22 JAN 2014 | DOI: 10.1111/bju.12466

    3. The prognostic significance of perineural invasion and race in men considering active surveillance

      Joshua A. Cohn, Pankaj P. Dangle, Chihsiung E. Wang, Charles B. Brendler, Kristian R. Novakovic, Michael S. McGuire and Brian T. Helfand

      Article first published online: 22 JAN 2014 | DOI: 10.1111/bju.12463

  38. Reviews

    1. Small renal mass biopsy – how, what and when: report from an international consensus panel

      Matvey Tsivian, Edward N. Rampersaud Jr, Maria del Pilar Laguna Pes, Steven Joniau, Raymond J. Leveillee, William B. Shingleton, Monish Aron, Charles Y. Kim, Angelo M. DeMarzo, Mihir M. Desai, James D. Meler, James F. Donovan, Hans Christoph Klingler, David R. Sopko, John F. Madden, Michael Marberger, Michael N. Ferrandino and Thomas J. Polascik

      Article first published online: 17 JAN 2014 | DOI: 10.1111/bju.12470

  39. Urological Oncology

    1. Occult lymph node metastases in patients with carcinoma invading bladder muscle: incidence after neoadjuvant chemotherapy and cystectomy vs after cystectomy alone

      Laura S. Mertens, Richard P. Meijer, Wim Meinhardt, Henk G. van der Poel, Axel Bex, J. Martijn Kerst, Michiel S. van der Heijden, Andries M. Bergman, Simon Horenblas and Bas W.G. van Rhijn

      Article first published online: 17 JAN 2014 | DOI: 10.1111/bju.12447

    2. A national survey of radiation oncologists and urologists on recommendations of prostate-specific antigen screening for prostate cancer

      Simon P. Kim, R. Jeffrey Karnes, Paul L. Nguyen, Jeanette Y. Ziegenfuss, R. Houston Thompson, Leona C. Han, Nilay D. Shah, Marc C. Smaldone, Cary P. Gross, Igor Frank, Christopher J. Weight, Timothy J. Beebe and Jon C. Tilburt

      Article first published online: 17 JAN 2014 | DOI: 10.1111/bju.12422

    3. Prognostic impact of baseline serum C-reactive protein in patients with metastatic renal cell carcinoma (RCC) treated with sunitinib

      Benoit Beuselinck, Yann-Alexandre Vano, Stéphane Oudard, Pascal Wolter, Robert De Smet, Lore Depoorter, Corine Teghom, Alexandra Karadimou, Jessica Zucman-Rossi, Philip R. Debruyne, Hendrik Van Poppel, Steven Joniau, Evelyne Lerut, Michiel Strijbos, Herlinde Dumez, Robert Paridaens, Ben Van Calster and Patrick Schöffski

      Article first published online: 15 JAN 2014 | DOI: 10.1111/bju.12494

  40. Translational Science

    1. Prognostic and diagnostic implications of epithelial cell adhesion/activating molecule (EpCAM) expression in renal tumours: a retrospective clinicopathological study of 948 cases using tissue microarrays

      Annette Zimpfer, Matthias Maruschke, Stefan Rehn, Guenter Kundt, Anke Litzenberger, Friederike Dammert, Heike Zettl, Carsten Stephan, Oliver W. Hakenberg and Andreas Erbersdobler

      Article first published online: 15 JAN 2014 | DOI: 10.1111/bju.12487

  41. Urological Oncology

    1. Progression and predictors of physical activity levels after radical prostatectomy

      Inge Geraerts, Hendrik Van Poppel, Nele Devoogdt, Annouschka Laenen, An De Groef and Marijke Van Kampen

      Article first published online: 15 JAN 2014 | DOI: 10.1111/bju.12465

    2. Population-based determinants of radical prostatectomy operative time

      Stacey C. Carter, Stuart Lipsitz, Ya-Chen T. Shih, Paul L. Nguyen, Quoc-Dien Trinh and Jim C. Hu

      Article first published online: 15 JAN 2014 | DOI: 10.1111/bju.12451

    3. Should centralized histopathological review in penile cancer be the global standard?

      Vincent Tang, Laurence Clarke, Zara Gall, Jonathan H. Shanks, Daisuke Nonaka, Nigel J. Parr, P. Anthony Elliott, Noel W. Clarke, Vijay Ramani, Maurice W. Lau and Vijay K. Sangar

      Article first published online: 15 JAN 2014 | DOI: 10.1111/bju.12449

    4. Prognostic value of inflammation or granuloma after intravesival BCG in non-muscle-invasive bladder cancer

      Samer Jallad, Stephanie Goubet, Andrew Symes, Timothy Larner and Philip Thomas

      Article first published online: 20 DEC 2013 | DOI: 10.1111/bju.12334

    5. Prospective analysis of penile length changes after radical prostatectomy

      Boback M. Berookhim, Christian J. Nelson, Brian Kunzel, John P. Mulhall and Joseph B. Narus

      Article first published online: 2 DEC 2013 | DOI: 10.1111/bju.12443

    6. Bladder outlet obstruction (BOO) in men with castration-resistant prostate cancer

      Maximilian Rom, Matthias Waldert, Georg Schatzl, Natalia Swietek, Shahrokh F. Shariat and Tobias Klatte

      Article first published online: 2 DEC 2013 | DOI: 10.1111/bju.12438

    7. Evaluation of ABO blood group as a prognostic marker in renal cell carcinoma (RCC)

      Michela de Martino, Matthias Waldert, Andrea Haitel, Georg Schatzl, Shahrokh F. Shariat and Tobias Klatte

      Article first published online: 2 DEC 2013 | DOI: 10.1111/bju.12436

  42. Translational Science

    1. Polybromo-1 (PBRM1), a SWI/SNF complex subunit is a prognostic marker in clear cell renal cell carcinoma

      Walter H. da Costa, Mariana Rezende, Felipe C. Carneiro, Rafael M. Rocha, Isabela W. da Cunha, Dirce M. Carraro, Gustavo C. Guimaraes and Stenio de Cassio Zequi

      Article first published online: 2 DEC 2013 | DOI: 10.1111/bju.12426

  43. Urological Oncology

    1. Role of multiparametric 3.0-Tesla magnetic resonance imaging in patients with prostate cancer eligible for active surveillance

      Bong H. Park, Hwang G. Jeon, Seol H. Choo, Byong C. Jeong, Seong I. Seo, Seong S. Jeon, Han Y. Choi and Hyun M. Lee

      Article first published online: 2 DEC 2013 | DOI: 10.1111/bju.12423

    2. Functional and oncological outcomes of patients aged <50 years treated with radical prostatectomy for localised prostate cancer in a European population

      Andreas Becker, Pierre Tennstedt, Jens Hansen, Quoc-Dien Trinh, Luis Kluth, Nabil Atassi, Thorsten Schlomm, Georg Salomon, Alexander Haese, Lars Budaeus, Uwe Michl, Hans Heinzer, Hartwig Huland, Markus Graefen and Thomas Steuber

      Article first published online: 2 DEC 2013 | DOI: 10.1111/bju.12407

  44. Translational Science

    1. Single nucleotide polymorphisms in fibroblast growth factor 23 gene, FGF23, are associated with prostate cancer risk

      Hae Jong Kim, Kyeoung-Hwa Kim, Jaehyouk Lee, Jong Jin Oh, Hyun Sub Cheong, Ee Lin Wong, Beom-Seok Yang, Seok Soo Byun and Soon Chul Myung

      Article first published online: 2 DEC 2013 | DOI: 10.1111/bju.12396

    2. MRI-safe robot for targeted transrectal prostate biopsy: animal experiments

      Govindarajan Srimathveeravalli, Chunwoo Kim, Doru Petrisor, Paula Ezell, Jonathan Coleman, Hedvig Hricak, Stephen B. Solomon and Dan Stoianovici

      Article first published online: 2 DEC 2013 | DOI: 10.1111/bju.12335

  45. Urological Oncology

    1. Clinical trial risk in castration-resistant prostate cancer: immunotherapies show promise

      Alessandro Tenuta, Laurence Klotz and Jayson L. Parker

      Article first published online: 2 DEC 2013 | DOI: 10.1111/bju.12309

    2. Validation of pretreatment neutrophil–lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma

      Orietta Dalpiaz, Georg C. Ehrlich, Sebastian Mannweiler, Jessica M.Martín Hernández, Armin Gerger, Tatjana Stojakovic, Karl Pummer, Richard Zigeuner, Martin Pichler and Georg C. Hutterer

      Article first published online: 27 NOV 2013 | DOI: 10.1111/bju.12441

    3. Progression to detrusor muscle invasion during urothelial carcinoma surveillance is associated with poor prognosis

      Rodney H. Breau, R. Jeffrey Karnes, Sara A. Farmer, Prabin Thapa, Ilias Cagiannos, Christopher Morash and Igor Frank

      Article first published online: 27 NOV 2013 | DOI: 10.1111/bju.12403

    4. A positive real-time elastography is an independent marker for detection of high-risk prostate cancers in the primary biopsy setting

      Yngve Nygård, Svein A. Haukaas, Ole J. Halvorsen, Karsten Gravdal, Jannicke Frugård, Lars A. Akslen and Christian Beisland

      Article first published online: 27 NOV 2013 | DOI: 10.1111/bju.12401

    5. The 1-year decline in estimated glomerular filtration rate (eGFR) after radical nephrectomy in patients with renal masses and matched living kidney donors is the same

      Miki N. Hew, Dedan Opondo, Ernesto R. Cordeiro, Karlijn A.M.I. van Donselaar-van der Pant, Frederike J. Bemelman, Mirza M. Idu, Jean J.M.C.H. de la Rosette and M. Pilar Laguna

      Article first published online: 31 OCT 2013 | DOI: 10.1111/bju.12345

    6. National prospective study on the use of local haemostatic agents during partial nephrectomy

      Herve Lang, Pascal Mouracade, Pierre Gimel, Jean C. Bernhard, Geraldine Pignot, Laurent Zini, Maxime Crepel, Jerome Rigaud, Laurent Salomon, Laurent Bellec, Christophe Vaessen, Morgan Roupret, Jean L. Jung, Eric Mourey, Xavier Martin, Pierre Bigot, Franck Bruyère, Julien Berger, Jean P. Ansieau, Franck Salome, Jacques Hubert, Christian Pfister, François Trifard, Marc Gigante, Herve Baumert, Arnaud Méjean and Jean J. Patard

      Article first published online: 31 OCT 2013 | DOI: 10.1111/bju.12397

    7. Prostate-specific antigen doubling time as a progression criterion in an active surveillance programme for patients with localized prostate cancer

      Frederik Birkebæk Thomsen, Ib Jarle Christensen, Klaus Brasso, Martin Andreas Røder and Peter Iversen

      Article first published online: 31 OCT 2013 | DOI: 10.1111/bju.12367

  46. Robotics and Laparoscopy

    1. Laparoendoscopic single-site (LESS) robot-assisted nephroureterectomy: comparison with conventional multiport technique in the management of upper urinary tract urothelial carcinoma

      Sey Kiat Lim, Tae-Young Shin, Kwang Hyun Kim, Woong Kyu Han, Byung Ha Chung, Sung Joon Hong, Young Deuk Choi and Koon Ho Rha

      Article first published online: 31 OCT 2013 | DOI: 10.1111/bju.12356

  47. Translational Science

    1. Electrocautery-induced cavernous nerve injury in rats that mimics radical prostatectomy in humans

      Lu-Jie Song, Jian-Qiang Zhu, Min-Kai Xie, Yong-Chuan Wang, Hong-Bin Li, Zhi-Qiang Cui, Hong-Kai Lu and Yue-Min Xu

      Article first published online: 31 OCT 2013 | DOI: 10.1111/bju.12348

  48. Urological Oncology

  49. Surgical Education

    1. Learning curves for urological procedures: a systematic review

      Hamid Abboudi, Mohammed Shamim Khan, Khurshid A. Guru, Saied Froghi, Gunter de Win, Hendrik Van Poppel, Prokar Dasgupta and Kamran Ahmed

      Article first published online: 24 OCT 2013 | DOI: 10.1111/bju.12315

  50. Urological Oncology

    1. Eligibility for neoadjuvant/adjuvant cisplatin-based chemotherapy among radical cystectomy patients

      R. Houston Thompson, Stephen A. Boorjian, Simon P. Kim, John C. Cheville, Prabin Thapa, Robert Tarrel, Roxana Dronca, Brian Costello and Igor Frank

      Article first published online: 5 SEP 2013 | DOI: 10.1111/bju.12274

  51. Translational Science

  52. Urological Oncology

  53. Review Articles

    1. Management of low (favourable)-risk prostate cancer

      H. Ballentine Carter

      Article first published online: 6 SEP 2011 | DOI: 10.1111/j.1464-410X.2011.10489.x

  54. Sexual Medicine

    1. THIS ARTICLE HAS BEEN RETRACTED Physical therapy for premature ejaculation, erectile dysfunction and chronic pelvic pain syndrome

      Helena M. Nugteren, Willibrord C.M. Weijmar Schultz and Mels F. van Driel

      Article first published online: 7 DEC 2009 | DOI: 10.1111/j.1464-410X.2009.09094.x

VIEW

  1. 1 - 90

SEARCH

SEARCH BY CITATION